You just read:

Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrig's Disease (ALS)

News provided by

Adeona Pharmaceuticals, Inc.

Jun 23, 2011, 09:00 ET